Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
SWOG Cancer Research Network
University Hospital, Clermont-Ferrand
National Institutes of Health Clinical Center (CC)
University College Cork
Kaiser Permanente
AstraZeneca
Context Therapeutics Inc.